These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 25081196)

  • 1. Relationship between cardio-ankle vascular index and N-terminal pro-brain natriuretic peptide in hypertension and coronary heart disease subjects.
    Wang H; Liu J; Zhao H; Zhou Y; Zhao X; Song Y; Li L; Shi H
    J Am Soc Hypertens; 2014 Sep; 8(9):637-43. PubMed ID: 25081196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descriptive study of relationship between cardio-ankle vascular index and biomarkers in vascular-related diseases.
    Liu J; Liu H; Zhao H; Shang G; Zhou Y; Li L; Wang H
    Clin Exp Hypertens; 2017; 39(5):468-472. PubMed ID: 28544855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cardio-ankle vascular index and homocysteine in hypertension subjects with hyperhomocysteinemia.
    Liu J; Liu H; Zhao H; Zhou Y; Li L; Wang H
    Clin Exp Hypertens; 2016; 38(7):652-657. PubMed ID: 27653661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients.
    Gür M; Uçar H; Kuloğlu O; Kıvrak A; Şeker T; Türkoğlu C; Özaltun B; Kaypaklı O; Şahin DY; Elbasan Z; Tanboğa Hİ; Çaylı M
    Clin Exp Hypertens; 2014; 36(6):374-9. PubMed ID: 24432984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal Pro-B-type Natriuretic Peptide is Associated with Arterial Stiffness as Measured According to the Brachial-ankle Pulse Wave Velocity in Patients with Takayasu Arteritis.
    Liu Q; Dang AM; Chen BW; Lv NQ; Wang X; Zheng DY
    J Atheroscler Thromb; 2015; 22(6):628-36. PubMed ID: 25503292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis.
    Hildebrandt P; Boesen M; Olsen M; Wachtell K; Groenning B
    Eur J Heart Fail; 2004 Mar; 6(3):313-7. PubMed ID: 14987582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects.
    Wang H; Liu J; Zhao H; Fu X; Shang G; Zhou Y; Yu X; Zhao X; Wang G; Shi H
    J Am Soc Hypertens; 2013; 7(6):426-31. PubMed ID: 23871571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
    Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
    Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium excretion and risk of developing coronary heart disease.
    Joosten MM; Gansevoort RT; Mukamal KJ; Lambers Heerspink HJ; Geleijnse JM; Feskens EJ; Navis G; Bakker SJ;
    Circulation; 2014 Mar; 129(10):1121-8. PubMed ID: 24425751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
    Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
    J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
    Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L
    Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects.
    Wang H; Liu J; Zhao H; Zhao X; Li L; Shi H; Zhan S; Liu J
    J Hum Hypertens; 2015 Feb; 29(2):105-8. PubMed ID: 24831100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide is associated with arterial stiffness measured using the cardio-ankle vascular index in renal transplant recipients.
    Chen YC; Lee MC; Lee CJ; Ho GJ; Yin WY; Chang YJ; Hsu BG
    J Atheroscler Thromb; 2013; 20(7):646-53. PubMed ID: 23665842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    Hypertension; 2005 Oct; 46(4):660-6. PubMed ID: 16129819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.